Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MDA To Increase Audits Of Notified Bodies, Manufacturers During 1999-2000

This article was originally published in The Gray Sheet

Executive Summary

The UK's Medical Devices Agency (MDA) intends to audit the performance of active notified bodies in Britain "at least once a year" and take "any action necessary" to maintain standards of performance "at the required level," the agency states in its recently released "Business Plan 1999-2000."

You may also be interested in...



EU Notified Bodies Vigilant In Checking Technical Files - British Survey

A survey of six European Union notified bodies (NBs) located in the UK (four), Germany (one) and Ireland (one) showed that "nearly 100%" inspected the technical files for CE-marked products during initial device manufacturer audits, John Worroll, section head, regulatory affairs and European business, UK Medical Devices Agency (MDA), said.

U.K. To Begin Clinical, Cost-Effectiveness Device Assessments Next Month

Britain's National Institute of Clinical Excellence (NICE) plans to conduct on an annual basis clinical and cost-effectiveness evaluations of between 30 and 50 new and existing medical technologies, Edward Hutt, division director Quintiles Medical Technology Consultants, said March 14.

California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012034

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel